Steven Cohen Oric Pharmaceuticals, Inc. Call Options Transaction History
Point72 Asset Management, L.P.
- $36 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORIC
# of Institutions
112Shares Held
63.1MCall Options Held
0Put Options Held
0-
Nextech Invest Ag5.29MShares$54.2 Million7.05% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$49.5 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.39MShares$45 Million3.41% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.14MShares$42.5 Million1.73% of portfolio
-
Viking Global Investors LP4MShares$41 Million0.11% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $406M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...